APA (7th ed.) Citation

Lal, R., Ellenbogen, A., Chen, D., Zomorodi, K., Atluri, H., Luo, W., . . . Cundy, K. C. (2012). A randomized, double-blind, placebo-controlled, dose-response study to assess the pharmacokinetics, efficacy, and safety of gabapentin enacarbil in subjects with restless legs syndrome. Clinical neuropharmacology, 35(4), 165. https://doi.org/10.1097/WNF.0b013e318259eac8

Chicago Style (17th ed.) Citation

Lal, Ritu, et al. "A Randomized, Double-blind, Placebo-controlled, Dose-response Study to Assess the Pharmacokinetics, Efficacy, and Safety of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome." Clinical Neuropharmacology 35, no. 4 (2012): 165. https://doi.org/10.1097/WNF.0b013e318259eac8.

MLA (9th ed.) Citation

Lal, Ritu, et al. "A Randomized, Double-blind, Placebo-controlled, Dose-response Study to Assess the Pharmacokinetics, Efficacy, and Safety of Gabapentin Enacarbil in Subjects with Restless Legs Syndrome." Clinical Neuropharmacology, vol. 35, no. 4, 2012, p. 165, https://doi.org/10.1097/WNF.0b013e318259eac8.